Podcast Inside Complex Pharma | Ep. 5
In the fifth episode, we turn our attention to a highly topical subject: the path from supply shortages to genuine supply sovereignty. Pharmaceutical production today is far more than a purely entrepreneurial activity — it is critical societal infrastructure. Investments in this area determine whether supply chains remain stable and whether Europe is capable of acting in times of crisis.
We discuss, among other things:
- Why investments in production must be understood as location policy, not merely as corporate strategy.
- Why emergency stockpiles only alleviate symptoms, but do not resolve the underlying structural cost-price imbalance.
- Why effective, future-oriented employee management is a central game-changer for sustainable corporate success.
General Manager Christoph Reinwald sums it up:
“Supply sovereignty does not arise ad hoc — it is the result of long-term capacity planning, investment security and reliable framework conditions.”